193 related articles for article (PubMed ID: 33754827)
1. Associations of Brain Atrophy and Cerebral Iron Accumulation at MRI with Clinical Severity in Wilson Disease.
Dusek P; Lescinskij A; Ruzicka F; Acosta-Cabronero J; Bruha R; Sieger T; Hajek M; Dezortova M
Radiology; 2021 Jun; 299(3):662-672. PubMed ID: 33754827
[TBL] [Abstract][Full Text] [Related]
2. Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study.
Dusek P; Bahn E; Litwin T; Jabłonka-Salach K; Łuciuk A; Huelnhagen T; Madai VI; Dieringer MA; Bulska E; Knauth M; Niendorf T; Sobesky J; Paul F; Schneider SA; Czlonkowska A; Brück W; Wegner C; Wuerfel J
Neuropathol Appl Neurobiol; 2017 Oct; 43(6):514-532. PubMed ID: 27543917
[TBL] [Abstract][Full Text] [Related]
3. Whole brain volume and cortical thickness abnormalities in Wilson's disease: a clinical correlation study.
Song Y; Zou L; Zhao J; Zhou X; Huang Y; Qiu H; Han H; Yang Z; Li X; Tang X; Chu J
Brain Imaging Behav; 2021 Aug; 15(4):1778-1787. PubMed ID: 33052506
[TBL] [Abstract][Full Text] [Related]
4. Distinctive Pattern of Metal Deposition in Neurologic Wilson Disease: Insights From 7T Susceptibility-Weighted Imaging.
Su D; Zhang Z; Zhang Z; Zheng S; Yao T; Dong Y; Zhu W; Wei N; Suo Y; Liu X; Zhao H; Wang Z; Ma H; Li W; Zhou J; Lam JST; Wu T; Dusek P; Stoessl AJ; Wang X; Jing J; Feng T
Neurology; 2024 Jun; 102(12):e209478. PubMed ID: 38830145
[TBL] [Abstract][Full Text] [Related]
5. Paramagnetic Metal Accumulation in the Deep Gray Matter Nuclei Is Associated With Neurodegeneration in Wilson's Disease.
Yuan XZ; Li GY; Chen JL; Li JQ; Wang XP
Front Neurosci; 2020; 14():573633. PubMed ID: 33041766
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics of patients with delayed hepatolenticular degeneration].
Zhou XX; Qin HL; He RX; Chen DB; Wu C; Feng L; Li XH; Liang XL
Zhonghua Nei Ke Za Zhi; 2019 Jul; 58(7):501-507. PubMed ID: 31269566
[No Abstract] [Full Text] [Related]
7. Magnetic Susceptibility Changes in the Basal Ganglia and Brain Stem of Patients with Wilson's Disease: Evaluation with Quantitative Susceptibility Mapping.
Doganay S; Gumus K; Koc G; Bayram AK; Dogan MS; Arslan D; Gumus H; Gorkem SB; Ciraci S; Serin HI; Coskun A
Magn Reson Med Sci; 2018 Jan; 17(1):73-79. PubMed ID: 28515413
[TBL] [Abstract][Full Text] [Related]
8. Metal deposits associated with brain atrophy in the deep gray matter nucleus in Wilson's disease.
Huang Z; Yang J; Chen D; Zhou X; Xiao X; Wang J; Wang M; Zhao J; Chu J
Cereb Cortex; 2023 Jul; 33(15):9223-9232. PubMed ID: 37365842
[TBL] [Abstract][Full Text] [Related]
9. Characterizing brain mineral deposition in patients with Wilson disease using susceptibility-weighted imaging.
Zhou XX; Qin HL; Li XH; Huang HW; Liang YY; Liang XL; Pu XY
Neurol India; 2014; 62(4):362-6. PubMed ID: 25237939
[TBL] [Abstract][Full Text] [Related]
10. Eye movement abnormalities are associated with brainstem atrophy in Wilson disease.
Hanuška J; Dušek P; Rusz J; Ulmanová O; Burgetová A; Růžička E
Neurol Sci; 2020 May; 41(5):1097-1103. PubMed ID: 31897936
[TBL] [Abstract][Full Text] [Related]
11. Plasma neurofilament light chain as a biomarker in Wilson's disease.
Yang J; Huang Z; Yang H; Luo Y; You H; Chen D; Pei Z; Li X
Parkinsonism Relat Disord; 2022 Feb; 95():5-10. PubMed ID: 34942565
[TBL] [Abstract][Full Text] [Related]
12. Correlation between neuroimaging, neurological phenotype, and functional outcomes in Wilson's disease.
Moura J; Pinto C; Freixo P; Alves H; Ramos C; Santos Silva E; Nery F; Gandara J; Lopes V; Ferreira S; Presa J; Ferreira JM; Miranda HP; Magalhães M
Neurol Sci; 2024 Jul; 45(7):3201-3208. PubMed ID: 38291197
[TBL] [Abstract][Full Text] [Related]
13. Neuroimaging correlates of brain injury in Wilson's disease: a multimodal, whole-brain MRI study.
Shribman S; Bocchetta M; Sudre CH; Acosta-Cabronero J; Burrows M; Cook P; Thomas DL; Gillett GT; Tsochatzis EA; Bandmann O; Rohrer JD; Warner TT
Brain; 2022 Mar; 145(1):263-275. PubMed ID: 34289020
[TBL] [Abstract][Full Text] [Related]
14. Does brain degeneration in Wilson disease involve not only copper but also iron accumulation?
Skowrońska M; Litwin T; Dzieżyc K; Wierzchowska A; Członkowska A
Neurol Neurochir Pol; 2013; 47(6):542-6. PubMed ID: 24374999
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility-Weighted Imaging Manifestations in the Brain of Wilson's Disease Patients.
Yang J; Li X; Yang R; Yu X; Yu C; Qian Y; Yu Y
PLoS One; 2015; 10(4):e0125100. PubMed ID: 25915414
[TBL] [Abstract][Full Text] [Related]
16. Free water imaging as a novel biomarker in Wilson's disease: A cross-sectional study.
Jing XZ; Li GY; Wu YP; Yuan XZ; Luo XG; Chen JL; Taximaimaiti R; Wang XP; Li JQ
Parkinsonism Relat Disord; 2023 Jan; 106():105234. PubMed ID: 36481719
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric Quantitative Brain MRI in Neurological and Hepatic Forms of Wilson's Disease.
Dezortova M; Lescinskij A; Dusek P; Herynek V; Acosta-Cabronero J; Bruha R; Jiru F; Robinson SD; Hajek M
J Magn Reson Imaging; 2020 Jun; 51(6):1829-1835. PubMed ID: 31710776
[TBL] [Abstract][Full Text] [Related]
18. Seven-tesla magnetic resonance imaging in Wilson disease using quantitative susceptibility mapping for measurement of copper accumulation.
Fritzsch D; Reiss-Zimmermann M; Trampel R; Turner R; Hoffmann KT; Schäfer A
Invest Radiol; 2014 May; 49(5):299-306. PubMed ID: 24220252
[TBL] [Abstract][Full Text] [Related]
19. Changes in brain susceptibility in Wilson's disease patients: a quantitative susceptibility mapping study.
Deng W; Zhang J; Yang J; Wang Z; Pan Z; Yue X; Zhao R; Qian Y; Yu Y; Li X
Clin Radiol; 2024 Feb; 79(2):e282-e286. PubMed ID: 38087682
[TBL] [Abstract][Full Text] [Related]
20. The asymmetry of neural symptoms in Wilson's disease patients detecting by diffusion tensor imaging, resting-state functional MRI, and susceptibility-weighted imaging.
Zhou XX; Li XH; Chen DB; Wu C; Feng L; Chu JP; Yang ZY; Li XB; Qin H; Li GD; Huang HW; Liang YY; Liang XL
Brain Behav; 2018 May; 8(5):e00930. PubMed ID: 29761003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
